Sangamo Therapeutics, Inc (SGMOQ) stock
SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.10−0.01 (-8.17%)
Close on Oct 19, 2026Market cap $39.43MP/E –Yield –
Sangamo Therapeutics statistics
40 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Mar 31, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 51.9%
- 10.8%
- Float
- 410M
- 49M
- Shares Held by Insiders
- 1.12%
- 11.6%
- Shares Held by Institutions
- 0.13%
- 56.4%
MarginsIndustry
- Pretax Margin
- -358.9%
- -11.6%
- EBITDA Margin
- -347.0%
- -27.7%
- FCF Margin
- -261.8%
- -9.56%
Returns on capitalIndustry
- Return on Assets (ROA)
- -168.8%
- -40.6%
- Return on Capital Employed (ROCE)
- -1808.8%
- -38.0%
Financial positionIndustry
- Current Ratio
- 0.70
- 3.30
- Quick Ratio
- 0.54
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- -45.8%
- 6.82%
- Revenue Growth (3Y CAGR)
- -29.2%
- 2.25%
- Revenue Growth (5Y CAGR)
- -19.7%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.47
- 0.40
- Revenue Per Employee
- $243.36K
- $429.29K
- Profits Per Employee
- -$868.52K
- -$690.06K
- Employee Count
- 142
- 75
Income statement (TTM)Industry
- Pretax Income
- -$124.02M
- -$12.98M
Balance sheetIndustry
- Net Cash (Debt)
- $27.59M
- $17.80M
- Net Cash Per Share
- $0.07
- $0.80
- Equity (Book Value)
- -$18.96M
- $53.27M
- Book Value Per Share
- -$0.05
- $1.50
- Tangible Book Value
- -$18.96M
- $26.82M
- Working Capital
- -$16.02M
- $79.93M
Cash flow (TTM)Industry
- Capital Expenditures
- -$115.00K
- -$1.00M
- FCF Per Share
- -$0.22
- -$0.42
Taxes and interestIndustry
- Income Tax
- -$687.00K
- $73.00K
Scores and fair valueIndustry
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | SGMOQ | S&P 500 | Difference | SGMOQ per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -30.2% | +0.6% | −30.8 pts | ||
| 3 months | +55.7% | +3.4% | +52.3 pts | ||
| Year to date | -75.9% | +13.3% | −89.2 pts | ||
| 1 year | -84.2% | +16.6% | −100.8 pts | ||
| 3 years | -80.9% | +86.4% | −167.3 pts | -42.4% | +23.1% |
| 5 years | -98.8% | +81.9% | −180.7 pts | -58.8% | +12.7% |
| 10 years | -97.2% | +318.9% | −416.0 pts | -30.0% | +15.4% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
8M SGMOQ shares were sold short on Oct 30, 2026, down 2.1% from the previous report. At recent volumes it would take 4.9 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 8,348,367 | -2.1% | 1,705,832 | 4.9 |
| Oct 15, 2026 | 8,523,810 | -8.5% | 3,352,925 | 2.5 |
| Sep 30, 2026 | 9,314,967 | -13.1% | 2,790,715 | 3.3 |
| Sep 15, 2026 | 10,719,405 | +2.8% | 3,318,879 | 3.2 |
| Aug 31, 2026 | 10,425,868 | +4.9% | 6,187,016 | 1.7 |
| Aug 14, 2026 | 9,936,467 | -3.9% | 8,653,359 | 1.1 |
| Jul 31, 2026 | 10,336,148 | -1.3% | 4,543,760 | 2.3 |
| Jul 15, 2026 | 10,477,351 | -34.1% | 7,949,583 | 1.3 |
| Jun 30, 2026 | 15,896,609 | -35.8% | 24,284,749 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?